Aclipse Therapeutics

Aclipse Therapeutics is an innovative biopharmaceutical company dedicated to developing novel and highly differentiated drugs to address diseases with unmet medical needs. Aclipse Therapeutics' strategy is to reduce clinical development risks by combining new insights into disease pathways with novel formulations of existing drugs that inhibit these pathways, leveraging existing non-clinical and clinical data to create significant patent entry barriers.